Odronextamab
R1979-ONC-2075
Phase 3 small_molecule active
Quick answer
Odronextamab for Follicular Lymphoma (FL) is a Phase 3 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Follicular Lymphoma (FL)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active